Abstract

Analysis of yo-yo intermittent recovery test level-1 between batter and bowler in cricket

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The Yo-Yo Intermittent Recovery Test (Level 1) to discriminate elite junior Australian football players
James P Veale ... John S Carlson
Journal of Science and Medicine in Sport | VOL. 13
James P Veale, et. al.James P Veale ... John S Carlson
17 May 2009
Yo-Yo Intermittent Recovery Test Level 2 and Its Relationship With Other Typical Soccer Field Tests in Female Collegiate Soccer Players.
Robert G. Lockie ... Fabrice G. Risso
Journal of Strength and Conditioning Research | VOL. 31
Robert G. Lockie, et. al.Robert G. Lockie ... Fabrice G. Risso
01 Oct 2017
Association between aerobic performance and physiological responses in Yo-Yo intermittent recovery test level 2, and the futsal-specific intermittent endurance test in trained futsal players.
Abdolhossein Parnow ... Pallav Sengupta
Journal of basic and clinical physiology and pharmacology | VOL. -
Abdolhossein Parnow, et. al.Abdolhossein Parnow ... Pallav Sengupta
24 Jul 2024
Post-Exercise Recovery of Ultra-Short-Term Heart Rate Variability after Yo-Yo Intermittent Recovery Test and Repeated Sprint Ability Test.
Chin-Hwai Hung ... Filipe Manuel Clemente
International journal of environmental research and public health | VOL. 17
Chin-Hwai Hung, et. al.Chin-Hwai Hung ... Filipe Manuel Clemente
01 Jun 2020
View more papers

More From: Zenodo (CERN European Organization for Nuclear Research)

Paper Title
Journal
Date
Author
Differences in the genomic diversity, structure and inbreeding patterns in wild and managed populations of Agave potatorum used in the production of Tobalá mezcal in Southern México.
Zenodo (CERN European Organization for Nuclear Research) | VOL. -
10 Jul 2024
Data for peer review
...
Zenodo (CERN European Organization for Nuclear Research) | VOL. -
, et. al. ...
30 Jun 2024
Therapy-induced APOBEC3A drives evolution of resistance to targeted therapies in non-small cell lung cancer
...
Zenodo (CERN European Organization for Nuclear Research) | VOL. -
, et. al. ...
17 May 2024
How long should my personal statement be dermatology residency?
Zenodo (CERN European Organization for Nuclear Research) | VOL. -
10 May 2024
View more papers